Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sepranolone in PMDD
NCT01875718Phase 2Completed
- Sponsor
- Asarina Pharma AB
- Start
- Jan 2013
- Primary completion
- Jun 2014
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of sepranolone in Premenstrual Dysphoric Disorder (PMDD), sponsored by Asarina Pharma AB. Started Jan 2013; status: completed.
02
Drugs
sepranolone
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT01875718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01875718.